Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog

Journal of the American College of Cardiology

Volumn 39, Issue 8, 2002, Pages 1374-1379

  Perry, Gilbert J ^a   Wei, Chih Chang ^a   Hankes, Gerald H ^b   Dillon, S Ray ^b   Rynders, Patricia ^b   Mukherjee, Rupak ^c   Spinale, Francis G ^c   Dell'Italia, Louis J ^a,d  

^a University of Alabama at Birmingham   (United States)

^b AUBURN UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; ENZYME ACTIVITY; HEART CATHETERIZATION; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEART VENTRICLE REMODELING; LUNG CAPILLARY PRESSURE; MITRAL VALVE REGURGITATION; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR RESISTANCE;

ALABAMA; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BODY WEIGHT; CHYMASES; DISEASE MODELS, ANIMAL; DOGS; FEMALE; HEART VENTRICLES; HEMODYNAMIC PROCESSES; MALE; MITRAL VALVE INSUFFICIENCY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RENIN; SERINE ENDOPEPTIDASES; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 0037123151     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)01763-1     Document Type: Article

References (20)

1. Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
2. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: Results of the ELITE ventricular function substudy
3. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
4. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
5. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial
6. Effects of enalapril on mortality in severe heart failure
7. Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs
8. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation
9. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: Effects on ventricular and myocyte function
10. Left ventricular volume determined echocardiographically by using a constant LV epicardial long axis to short axis dimension ratio throughout the cardiac cycle
11. Sensitive HPLC assay for membrane-bound angiotensin-converting enzyme in tissue
12. 2 null mutant mice
13. 1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo
14. Localization and production of angiotensin II in the isolated perfused rat heart
15. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves
16. Native β-adrenergic support for left ventricular dysfunction in experimental mitral regurgitation normalizes indexes of pump and contractile function
17. ANG II modifies cardiomyocyte function via extracardiac and intracardiac neurons: In situ and in vitro studies
18. Angiotensin II modulates catecholamine release into the interstitial fluid of the canine myocardium in vivo
19. Extracellular matrix remodeling in heart failure. A role for de novo angiotensin II generation
20. Myocardial connective tissue alterations